Literature DB >> 28947127

Cognitive and behavioral changes in Huntington disease before diagnosis.

Jane S Paulsen1, Amanda C Miller2, Terry Hayes2, Emily Shaw2.   

Abstract

Phenotypic manifestations of Huntington disease (HD) can be detected at least 15 years prior to the time when a motor diagnosis is given. Advances in clinical care and future research will require consistent use of HD definitions and HD premanifest (prodromal) stages being used across clinics, sites, and countries. Cognitive and behavioral (psychiatric) changes in HD are summarized and implications for ongoing advancement in our knowledge of prodromal HD are suggested. The earliest detected cognitive changes are observed in the Symbol Digit Modalities Test, Stroop Interference, Stroop Color and Word Test-interference condition, and Trail Making Test. Cognitive changes in the middle and near motor diagnostic stages of prodromal HD involve nearly every cognitive test administered and the greatest changes over time (i.e., slopes) are found in those prodromal HD participants who are nearest to motor diagnosis. Psychiatric changes demonstrate significant worsening over time and remain elevated compared with healthy controls throughout the prodromal disease course. Psychiatric and behavior changes in prodromal HD are much lower than that obtained using cognitive assessment, although the psychiatric and behavioral changes represent symptoms most debilitating to independent capacity and wellness.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Huntington disease; behavioral; cognition; diagnosis; neuropsychology; personality; preclinical Huntington disease; premanifest Huntington disease; presymptomatic Huntington disease; prevention; preventive; prodromal Huntington disease; psychiatric; staging Huntington disease

Mesh:

Year:  2017        PMID: 28947127     DOI: 10.1016/B978-0-12-801893-4.00006-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  17 in total

Review 1.  Recent Advances in the Treatment of Huntington's Disease: Targeting DNA and RNA.

Authors:  Kathleen M Shannon
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

2.  Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI.

Authors:  Chiara Casella; Maxime Chamberland; Pedro L Laguna; Greg D Parker; Anne E Rosser; Elizabeth Coulthard; Hugh Rickards; Samuel C Berry; Derek K Jones; Claudia Metzler-Baddeley
Journal:  Hum Brain Mapp       Date:  2022-04-09       Impact factor: 5.399

3.  Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington's disease: a study of linked Swedish National Registries (2002-2019).

Authors:  Hannah Furby; Suzanne Moore; Anna-Lena Nordstroem; Richard Houghton; Dimitra Lambrelli; Sophie Graham; Per Svenningsson; Åsa Petersén
Journal:  J Neurol       Date:  2022-10-18       Impact factor: 6.682

4.  Comment on Clinical Profile of Genetically Proven Huntington's Disease Patients From Eastern India.

Authors:  Gustavo L Franklin; Carlos Henrique Camargo; Alex T Meira; Hélio A G Teive
Journal:  Ann Indian Acad Neurol       Date:  2020-06-24       Impact factor: 1.383

5.  Structural brain correlates of irritability and aggression in early manifest Huntington's disease.

Authors:  Saul Martinez-Horta; Frederic Sampedro; Andrea Horta-Barba; Jesús Perez-Perez; Javier Pagonabarraga; Beatriz Gomez-Anson; Jaime Kulisevsky
Journal:  Brain Imaging Behav       Date:  2021-02       Impact factor: 3.978

6.  Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.

Authors:  Katherine Osborne-Crowley; Sophie C Andrews; Izelle Labuschagne; Akshay Nair; Rachael Scahill; David Craufurd; Sarah J Tabrizi; Julie C Stout
Journal:  J Int Neuropsychol Soc       Date:  2019-02-15       Impact factor: 2.892

7.  Associations between prognostic index scores and plasma neurofilament light in Huntington's disease.

Authors:  Georgia M Parkin; Jody Corey-Bloom; Jeffrey D Long; Chase Snell; Haileigh Smith; Elizabeth A Thomas
Journal:  Parkinsonism Relat Disord       Date:  2022-03-04       Impact factor: 4.402

8.  Are the Results of a Combined Behavioural and Surgical Treatment of Morbid Obesity Satisfactory and Predictable?

Authors:  Per G Farup
Journal:  Nutrients       Date:  2020-07-05       Impact factor: 5.717

9.  Complex spatial and temporally defined myelin and axonal degeneration in Huntington disease.

Authors:  H D Rosas; P Wilkens; D H Salat; N D Mercaldo; M Vangel; A Y Yendiki; S M Hersch
Journal:  Neuroimage Clin       Date:  2018-02-19       Impact factor: 4.881

Review 10.  Exercise in Huntington's Disease: Current State and Clinical Significance.

Authors:  Sandro Manuel Mueller; Jens A Petersen; Hans H Jung
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.